当前位置: 首页 > 详情页

Where are we heading in post-China angioplasty and stenting for symptomatic intracranial severe stenosis era?

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ ESCI

机构: [1]Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China. [2]Department of Neurosurgery, Wayne State University School of Medicine, Detroit, MI, USA. [3]Department of Neurology, Xuanwu Hospital Capital Medical University, Beijing, China.
出处:
ISSN:

关键词: China angioplasty and stenting for symptomatic intracranial severe stenosis intracranial atherosclerotic disease stent

摘要:
Symptomatic intracranial atherosclerotic disease (ICAD) is a globally challengeable disease. In the past 20 years, people have made a huge effort to deal with the problem including using endovascular technology and aggressive medical therapy. However, the efficacy of these methods seemed to be limited. The recent China angioplasty and stenting for symptomatic intracranial severe stenosis (CASSISS) did not support the addition of percutaneous transluminal angioplasty and stenting to medical therapy for the treatment of patients with symptomatic severe ICAD. So where are we heading in the post-CASSISS era?Copyright: © 2023 Brain Circulation.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类 | 4 区 医学
小类 | 4 区 临床神经病学 4 区 神经科学
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 临床神经病学 4 区 神经科学
JCR分区:
出版当年[2021]版:
最新[2023]版:
Q3 CLINICAL NEUROLOGY Q3 NEUROSCIENCES

影响因子: 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者:
第一作者机构: [1]Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
通讯作者:
通讯机构: [3]Department of Neurology, Xuanwu Hospital Capital Medical University, Beijing, China. [*1]Department of Neurology, Xuanwu Hospital Capital Medical University, Beijing, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16461 今日访问量:0 总访问量:871 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院